Search research articles
Contact Us
Filters
Showing results (611-620 of 959) with videos related to
Page
of 96
Sort By:
The Journal of Antimicrobial Chemotherapy
|
June 8, 2019
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL
Nicola Gianotti, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Open Medicine (Warsaw, Poland)
|
August 15, 2019
Primary Angiosarcoma of the Kidney: Case Report and Comprehensive Literature Review
Andrea Boni, Giovanni Cochetti, Angelo Sidoni, et al.
AIDS (London, England)
|
April 13, 2004
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy
Michela Violin, Alessandro Cozzi-Lepri, Rossella Velleca, et al.
AIDS (London, England)
|
April 7, 2007
Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen
Alessandro Cozzi-Lepri, Andrew N Phillips, Lidia Ruiz, et al.
HIV Medicine
|
August 24, 2010
Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008
M C F Prosperi, A Cozzi-Lepri, A Antinori, et al.
Antiviral Therapy
|
April 14, 2010
Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy
Antonella Castagna, Laura Galli, Carlo Torti, et al.
The Journal of Infectious Diseases
|
July 17, 2009
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings
Alessandro Cozzi-Lepri, Andrew N Phillips, Javier Martinez-Picado, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
June 20, 2022
Lepri Bernadin Nicaise Aka, Kouadio Daniel Ekra, Gnissan Henri Auguste Yao, et al.
HIV Medicine
|
June 30, 2010
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure
F Tordato, A Cozzi Lepri, P Cicconi, et al.
The Journal of Antimicrobial Chemotherapy
|
September 11, 2019
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort
Lucia Taramasso, Patrizia Lorenzini, Antonio Di Biagio, et al.
Page
of 96
Search research articles
Search
Showing results (611-620 of 959) with videos related to
Sort By:
Page
of 96
The Journal of Antimicrobial Chemotherapy
|
June 8, 2019
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL
Nicola Gianotti, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Open Medicine (Warsaw, Poland)
|
August 15, 2019
Primary Angiosarcoma of the Kidney: Case Report and Comprehensive Literature Review
Andrea Boni, Giovanni Cochetti, Angelo Sidoni, et al.
AIDS (London, England)
|
April 13, 2004
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy
Michela Violin, Alessandro Cozzi-Lepri, Rossella Velleca, et al.
AIDS (London, England)
|
April 7, 2007
Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen
Alessandro Cozzi-Lepri, Andrew N Phillips, Lidia Ruiz, et al.
HIV Medicine
|
August 24, 2010
Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008
M C F Prosperi, A Cozzi-Lepri, A Antinori, et al.
Antiviral Therapy
|
April 14, 2010
Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy
Antonella Castagna, Laura Galli, Carlo Torti, et al.
The Journal of Infectious Diseases
|
July 17, 2009
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings
Alessandro Cozzi-Lepri, Andrew N Phillips, Javier Martinez-Picado, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
June 20, 2022
Lepri Bernadin Nicaise Aka, Kouadio Daniel Ekra, Gnissan Henri Auguste Yao, et al.
HIV Medicine
|
June 30, 2010
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure
F Tordato, A Cozzi Lepri, P Cicconi, et al.
The Journal of Antimicrobial Chemotherapy
|
September 11, 2019
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort
Lucia Taramasso, Patrizia Lorenzini, Antonio Di Biagio, et al.
Page
of 96